Further cell experiments revealed that RUNX1 could regulate the transcription and expression of IFNGR2 as well as participate in glioma cell proliferation, cycle, apoptosis, invasion, and migration, which may be realized through the IL2-STAT5 pathway. This evidence concerns the gene RUNX1 and central nervous system cancer.